The design of such heteroclitic peptides, where the stability of interaction between the peptide and MHC molecule is improved by replacement of certain aa was shown to be a powerful strategy for both improving CTL reactivity in vitro and controlling tumor growth in mice (144, 146–150). Here, HLA-C is linked to neoplasm.